- Home
- COGT vs MSC Comparison
COGT vs MSC Comparison
Compare COGT & MSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- MSC
- Stock Information
- Founded
- COGT 2014
- MSC 2000
- Country
- COGT United States
- MSC Hong Kong
- Employees
- COGT N/A
- MSC N/A
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- MSC Hotels/Resorts
- Sector
- COGT Health Care
- MSC Consumer Discretionary
- Exchange
- COGT Nasdaq
- MSC Nasdaq
- Market Cap
- COGT 895.8M
- MSC 1.0B
- IPO Year
- COGT 2018
- MSC 2018
- Fundamental
- Price
- COGT $8.03
- MSC $4.80
- Analyst Decision
- COGT Buy
- MSC
- Analyst Count
- COGT 6
- MSC 0
- Target Price
- COGT $14.17
- MSC N/A
- AVG Volume (30 Days)
- COGT 1.5M
- MSC 17.2K
- Earning Date
- COGT 02-24-2025
- MSC 02-27-2025
- Dividend Yield
- COGT N/A
- MSC N/A
- EPS Growth
- COGT N/A
- MSC N/A
- EPS
- COGT N/A
- MSC N/A
- Revenue
- COGT N/A
- MSC $627,533,000.00
- Revenue This Year
- COGT N/A
- MSC $33.86
- Revenue Next Year
- COGT N/A
- MSC $16.73
- P/E Ratio
- COGT N/A
- MSC N/A
- Revenue Growth
- COGT N/A
- MSC 103.40
- 52 Week Low
- COGT $4.28
- MSC $4.12
- 52 Week High
- COGT $12.61
- MSC $9.30
- Technical
- Relative Strength Index (RSI)
- COGT 46.50
- MSC 36.84
- Support Level
- COGT $6.60
- MSC $4.12
- Resistance Level
- COGT $8.72
- MSC $4.95
- Average True Range (ATR)
- COGT 0.51
- MSC 0.54
- MACD
- COGT 0.09
- MSC -0.06
- Stochastic Oscillator
- COGT 67.45
- MSC 25.28
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling.
About MSC Studio City International Holdings Limited
Studio City International Holdings Ltd is a gaming, retail, and entertainment resort located in Cotai, Macau. It operates Studio City Casino with around 250 mass-market gaming tables; including 15 tables for VIP rolling chip operations, and 552 gaming machines. Studio City features luxury hotel rooms, diverse food and beverage establishments, and complementary retail space. In addition, the company offers non-gaming attractions, including the world's first figure-8 Ferris wheel, a deluxe nightclub and karaoke venue, a live performance arena, an outdoor and an indoor water park. Geographically, the company derives the majority of its revenue from the Macau region.